Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.

Immunobiology

Key Laboratory of Transplant Engineering and Immunology of Health Ministry of China, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, PR China; Chinese Cochrane Centre, Chinese Evidence-Based Medicine Centre, Chengdu 610041, Sichuan Province, PR China. Electronic address:

Published: April 2015

Background: Immune response outcome, inflammation or tolerance, often depends on the balance between regulatory T cells (Tregs) and effective T cells (Teffs). Rapamycin (Rapa) has been reported to selectively expand Tregs and promote de novo generation of foxp3(+) Tregs, suggesting its potential role in inducing tolerance. But the mechanism by which Rapa regulating the Treg-Teff balance is yet to be understood.

Methods: Mouse CD4(+)CD25(-) Teffs and CD4(+)CD25(+) Tregs are sorted by MACS. These T cell subsets were labeled with CFSE and cultured with anti-CD3/CD28 Ab±IL-2 for 6 days. Two rounds of stimulation of 3 days each were performed. Rapa or Jak Inhibitor I was added to the culture when indicated. Cells were harvested after each round of stimulation. CFSE dilution, FOXP3, miR-155 expression and the signaling via the mTOR and STAT5 pathways were determined. And miR-155-mimic and miR-155-antagomir were transfected into purified CD4(+) T cells respectively to detect miR-155 role in regulating STAT5 signaling.

Results: Firstly, we confirmed that the effect of Rapa on proliferating T cells is time-dependent: it reduces both Teffs and Tregs proliferation at early stage, but selectively promotes Tregs proliferation after second round of stimulation. Then we found there is direct interaction between mTOR and STAT5 signaling, and this interaction explained the time-dependent effect of Rapa and may participate in deciding Teff-Treg balance: mTOR inhibition up-regulated the expression of phos-STAT5 in both proliferating Tregs and Teffs via miR-155. And foxp3 is the down streaming target of phos-STAT5, thus Rapa could maintain expanded Tregs function and promote de novo generation of foxp3(+) Tregs. However, the phos-4E-BP1 expression pattern is different in proliferating Tregs and Teffs. 4E-BP1 is the common target of mTOR and STAT5 signaling, and plays a key role in cell proliferation. Rapa inhibits phos-4E-BP1 expression in both Tregs and Teffs at early stage of proliferation, but selectively raises its expression in Tregs after second round of stimulation. This may explains why Rapa inhibits Teffs growth, but delays Tregs proliferation.

Conclusion: Together, these findings indicate that the dynamic interaction between mTOR and STAT5 signaling modulates the reciprocal differentiation of the effective and regulatory T cells, and differently affect their proliferation activity. This provides a new insight of how Treg-Teff balance is regulated.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.imbio.2014.10.020DOI Listing

Publication Analysis

Top Keywords

mtor stat5
20
stat5 signaling
16
tregs
13
round stimulation
12
tregs teffs
12
signaling modulates
8
balance regulatory
8
effective cells
8
regulatory cells
8
rapa
8

Similar Publications

Leptin promotes tendon stem/progenitor cell senescence through the AKT-mTOR signaling pathway.

Exp Cell Res

October 2024

Department of Orthropedics, Navy Medical Center of PLA, Naval Medical University, Shanghai, 200000, China. Electronic address:

Article Synopsis
  • Dysregulated production of adipokines like leptin is linked to tendon health, with high serum leptin connected to tendinopathy, although the mechanisms weren't clearly understood prior to this study.
  • This research focused on how leptin affects tendon stem/progenitor cells (TSPCs), revealing that increased leptin decreases their viability, induces cellular changes, and promotes aging within these cells.
  • The study found that leptin disrupts tendon healing by activating the AKT/mTOR signaling pathway, and using rapamycin can counteract its negative effects, highlighting the importance of managing high leptin levels for tendon recovery.
View Article and Find Full Text PDF

Hepatic-derived extracellular vesicles in late pregnancy promote mammary gland development by stimulating prolactin receptor-mediated JAK2/STAT5/mTOR signalling.

Int J Biol Macromol

November 2024

State Key Laboratory of Livestock and Poultry Breeding, Guangdong Provincial Key Laboratory of Animal Nutrition Control, National Engineering Research Center for Breeding Swine Industry, College of Animal Science, South China Agricultural University, No. 483 Wushan Road, Guangzhou 510642, China.. Electronic address:

Article Synopsis
  • The study investigates the role of hepatic-derived extracellular vesicles (P-hEVs) from pregnant mice in promoting mammary gland development, which is vital for lactation.
  • It was found that P-hEVs enhance the proliferation and differentiation of mammary epithelial cells, crucial for lactation preparation.
  • The underlying mechanism involves activation of specific signaling pathways, including PI3K/AKT and JAK2/STAT5/mTOR, that support mammary gland growth and milk protein synthesis.
View Article and Find Full Text PDF
Article Synopsis
  • Primary atopic disorders (PAD) are rare genetic conditions caused by specific gene variants that affect skin and immune function, making diagnosis challenging among common allergic disease cases.
  • Identifying PAD requires recognizing clinical red flags like family history and unusual infections, as conventional lab tests are inadequate for definitive diagnosis.
  • Whole-genome sequencing (WGS) enhances diagnostic efficiency and accuracy, but requires careful interpretation and collaboration among specialists to effectively manage PAD cases.
View Article and Find Full Text PDF

hFcγRIIa: a double-edged sword in osteoclastogenesis and bone balance in transgenic mice.

Front Immunol

September 2024

School of Biology and Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, China.

Rheumatoid arthritis (RA) is a chronic autoimmune disease accompanied by local and systemic bone loss. FcγRs, especially FcγRIIa (hFcγRIIa), have been implicated in the pathogenesis of RA. However, the contribution of hFcγRIIa to bone loss has not been fully elucidated.

View Article and Find Full Text PDF

Identification of PFKFB3 as a key factor in the development of colorectal cancer and immunotherapy resistance.

Clin Exp Med

September 2024

Zhejiang Provincial Key Laboratory of Pancreatic Disease, First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China.

Article Synopsis
  • Resistance to immunotherapy in colorectal cancer (CRC) is linked to the enzyme PFKFB3, which is found at higher levels in CRC tissues compared to normal ones.
  • Research shows that inhibiting PFKFB3 can reduce tumor growth and is associated with several cancer-related pathways and immune responses.
  • High expression of PFKFB3 is tied to immunotherapy resistance, particularly in patients resistant to PD-L1 blockade, highlighting its potential as a therapeutic target to improve treatment outcomes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!